|
77
|
257
|
2q1qA |
Carbonic anhydrase inhibitors. interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: kinetic and x-ray crystallographic studies |
|
74
|
257
|
2povA |
The crystal structure of the human carbonic anhydrase ii in complex with 4-amino-6-chloro-benzene-1,3-disulfonamide |
|
74
|
257
|
2osfA |
Inhibition of carbonic anhydrase ii by thioxolone: a mechanistic and structural study |
|
75
|
258
|
2osmA |
Inhibition of carbonic anhydrase ii by thioxolone: a mechanistic and structural study |
|
76
|
256
|
2o4zA |
Crystal structure of the carbonic anhydrase ii complexed with hydroxysulfamide inhibitor |
|
78
|
258
|
2nxrA |
Structural effects of hydrophobic mutations on the active site of human carbonic anhydrase ii |
|
75
|
258
|
2nwoA |
Structural and kinetic effect of hydrophobic mutations in the active site of human carbonic anhydrase ii |
|
77
|
258
|
2nngA |
Structure of inhibitor binding to carbonic anhydrase ii |
|
76
|
258
|
2nwzA |
Structural and kinetic effects of hydrophobic mutations on the active site of human carbonic anhydrase ii |
|
73
|
258
|
2nn1A |
Structure of inhibitor binding to carbonic anhydrase i |
|
74
|
258
|
2nxsA |
Structural and kinetic effects of hydrophobic mutations in the active site of human carbonic anhydrase ii |
|
74
|
258
|
2nmxA |
Structure of inhibitor binding to carbonic anhydrase i |
|
73
|
258
|
2nwpA |
Structural and kinetic effects of hydrophobic mutations in the active site of human carbonic anhydrase ii |
|
79
|
258
|
2nxtA |
Structural and kinetic effects of hydrophobic mutations in the active site of human carbonic anhydrase ii |
|
76
|
259
|
2nnoA |
Structure of inhibitor binding to carbonic anhydrase ii |
|
74
|
258
|
2nn7A |
Structure of inhibitor binding to carbonic anhydrase i |
|
77
|
259
|
2nnsA |
Structure of inhibitor binding to carbonic anhydrase ii |
|
76
|
258
|
2nwyA |
Structural and kinetic effects of hydrophobic mutations on the active site of human carbonic anhydrase ii |
|
74
|
259
|
2nnvA |
Structure of inhibitor binding to carbonic anhydrase ii |
|
71
|
256
|
2it4A |
X ray structure of the complex between carbonic anhydrase i and the phosphonate antiviral drug foscarnet |
|
76
|
258
|
2iliA |
Refine atomic structure of human carbonic anhydrase ii |
|
74
|
258
|
2hocA |
Crystal structure of the human carbonic anhydrase ii in complex with the 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide inhibitor |
|
68
|
257
|
2hfwA |
Structural and kinetic analysis of proton shuttle residues in the active site of human carbonic anhydrase iii |
|
76
|
257
|
2hl4A |
Crystal structure analysis of human carbonic anhydrase ii in complex with a benzenesulfonamide derivative |
|
74
|
257
|
2hd6A |
Crystal structure of the human carbonic anhydrase ii in complex with a hypoxia-activatable sulfonamide. |
|
74
|
257
|
2hncA |
Crystal structure of the human carbonic anhydrase ii in complex with the 5-amino-1,3,4-thiadiazole-2-sulfonamide inhibitor. |
|
78
|
256
|
2hkkA |
Carbonic anhydrase activators: solution and x-ray crystallography for the interaction of andrenaline with various carbonic anhydrase isoforms |
|
75
|
257
|
2h4nA |
H94n carbonic anhydrase ii complexed with acetazolamide |
|
77
|
256
|
2h15A |
Carbonic anhydrase inhibitors: clashing with ala65 as a means of designing isozyme-selective inhibitors that show low affinity for the ubiquitous isozyme ii |
|
75
|
257
|
2gehA |
N-hydroxyurea, a versatile zinc binding function in the design of metalloenzyme inhibitors |
|
80
|
257
|
2gd8A |
Crystal structure analysis of the human carbonic anhydrase ii in complex with a 2-substituted estradiol bis-sulfamate |
|
78
|
258
|
2fnnA |
Activation of human carbonic anhydrase ii by exogenous proton donors |
|
74
|
259
|
2fovA |
Human carbonic anhydrase ii complexed with two-prong inhibitors |
|
80
|
257
|
2fmzA |
Carbonic anhydrase activators. activation of isoforms i, ii, iv, va, vii and xiv with l- and d- phenylalanine, structure with d-phenylalanine. |
|
75
|
260
|
2fouA |
Human carbonic anhydrase ii complexed with two-prong inhibitors |
|
78
|
258
|
2fnmA |
Activation of human carbonic anhdyrase ii by exogenous proton donors |
|
74
|
257
|
2foqA |
Human carbonic anhydrase ii complexed with two-prong inhibitors |
|
79
|
257
|
2fmgA |
Carbonic anhydrase activators. activation of isoforms i, ii, iv, va, vii and xiv with l- and d- phenylalanine and crystallographic analysis of their adducts with isozyme ii: sterospecific recognition within the active site of an enzyme and its consequences for the drug design, structure with l-phenylalanine |
|
74
|
259
|
2fosA |
Human carbonic anhydrase ii complexed with two-prong inhibitors |
|
72
|
256
|
2foyA |
Human carbonic anhydrase i complexed with a two-prong inhibitor |
|
75
|
258
|
2fnkA |
Activation of human carbonic anhydrase ii by exogenous proton donors |
|
69
|
257
|
2fw4A |
Carbonic anhydrase activators. the first x-ray crystallographic study of an activator of isoform i, structure with l-histidine. |
|
74
|
257
|
2eu2A |
Human carbonic anhydrase ii in complex with novel inhibitors |
|
74
|
257
|
2f14A |
Tne crystal structure of the human carbonic anhydrase ii in complex with a fluorescent inhibitor |
|
74
|
256
|
2eu3A |
Human carbonic anhydrase ii in complex with novel inhibitors |
|
78
|
258
|
2ez7A |
Carbonic anhydrase activators. activation of isozymes i, ii, iv, va, vii and xiv with l- and d-histidine and crystallographic analysis of their adducts with isoform ii: engineering proton transfer processes within the active site of an enzyme |
|
80
|
258
|
2cbdA |
Structure of native and apo carbonic anhydrase ii and some of its anion-ligand complexes |
|
80
|
258
|
2cbbA |
Structure of native and apo carbonic anhydrase ii and some of its anion-ligand complexes |
|
75
|
256
|
2cabA |
Structure, refinement and function of carbonic anhydrase isozymes. refinement of human carbonic anhydrase i |
|
79
|
258
|
2cbeA |
Structure of native and apo carbonic anhydrase ii and some of its anion-ligand complexes |
